Skip to main content
SpringerLink
Log in

Adalimumab

Various toxicities: 7 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Harigai M, et al. Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients. Modern rheumatology / the Japan Rheumatism Association 28: 30-38, No. 1, 2018. Available from: URL: http://doi.org/10.1080/14397595.2017.1304159 - Japan

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1691, 18 (2018). https://doi.org/10.1007/s40278-018-42273-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-42273-z

Search

Navigation